Previous 10 | Next 10 |
The shares of Chimerix (NASDAQ:CMRX) rose on Friday after the company announced that Public Health Agency of Canada awarded it a contract to deliver up to $25.3M of Tembexa (brincidofovir), a treatment approved in the U.S. for smallpox. On Thursday, Chimerix (CMRX) announced an agreement with...
Emergent BioSolutions (NYSE:EBS) announced on Friday that the FDA accepted its Biologics License Application (BLA) for the investigational anthrax vaccine AV7909 with a Prescription Drug User Fee Act goal date in April 2023 for review. The company has developed AV7909 for post-exposure prophy...
GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted). AV7909 is the company...
Companies targeting the monkeypox virus are on the rise in the pre-market Thursday as an Emergency Committee of the World Health Organization (WHO) meets today to decide whether to declare the latest outbreak a public health emergency of international concern. PHEIC designation is WHO's ...
GAITHERSBURG, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that two-year persistence data from its phase 2 clinical study evaluating the safety and immunogenicity of the company’s investigational chikungunya virus virus-like particle (C...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
The World Health Organization (WHO) is set to convene a meeting of an Emergency Committee on Thursday next week to establish whether the monkeypox outbreak represents a public health emergency of international concern. PHEIC label is the highest level of warning issued by the global body, whi...
The EU is set to ink a deal to secure ~110K doses of monkeypox vaccine from an undisclosed manufacturer, Reuters reported citing EU health commissioner Stella Kyriakides. Deliveries for the vaccine will begin from June end, according to the report. Kyriakides noted that the doses wi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amid brewing economic concerns, investors seeking upside opportunities in the equities sector should consider biotech stocks to buy for one simple reason: extraordinary and permanent relevance. No matter what happens to the...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Once a problem confined to just one continent, Monkeypox is spreading and threatens to become a global issue. Since the United Kingdom first reported a confirmed Monkeypox case on May 7, many more cases have been reported ...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...